| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| O Serri, G Renier, M Somm. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Hormone research. vol 21. issue 2. 1985-05-23. PMID:3979949. |
the interaction of metoclopramide with striatal dopaminergic receptors was slightly modified, while that of dopamine, bromocriptine and haloperidol was unaffected. |
1985-05-23 |
2023-08-11 |
rat |
| L A Ristine, L P Spea. Is there a "serotonergic syndrome" in neonatal rat pups? Pharmacology, biochemistry, and behavior. vol 22. issue 2. 1985-05-09. PMID:2858868. |
pretreatment with the alpha-noradrenergic antagonist phentolamine partially attenuated the quipazine-induced increase in mouthing, with both phentolamine and the dopaminergic antagonist haloperidol exhibiting some tendency to suppress the forward locomotion induced by quipazine. |
1985-05-09 |
2023-08-11 |
rat |
| I Fazekas, H Medzihradszky-Schweiger, G Rappay, Z Acs, M Fekete, A Gyéva. Responsiveness of intermediate lobe cells to neural mediators in culture. Experimental and clinical endocrinology. vol 84. issue 3. 1985-04-18. PMID:6098487. |
the inhibition is probably mediated by specific dopaminergic receptors, since simultaneously added haloperidol prevented the dopamine induced hormone release inhibition. |
1985-04-18 |
2023-08-12 |
rat |
| V V Petkov, V D Petkov, T Grahovska, E Konstantinov. Enkephalin receptor changes in rat brain during aging. General pharmacology. vol 15. issue 6. 1985-04-18. PMID:6098514. |
the studies with repeated administration of l-dopa or haloperidol provided further evidence for interactions between opiate and dopaminergic systems. |
1985-04-18 |
2023-08-12 |
rat |
| H B Niznik, J H Guan, J L Neumeyer, P Seema. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride. Molecular pharmacology. vol 27. issue 2. 1985-03-21. PMID:3969068. |
similarly, dopaminergic antagonists prevented the photoinactivation of d2 receptors by azidoclebopride with the following order of potency: spiperone greater than (+)-butaclamol greater than haloperidol greater than clebopride greater than (-)-sulpiride greater than (-)-butaclamol. |
1985-03-21 |
2023-08-11 |
Not clear |
| G Mereu, B Fanni, M Collu, A Diena, A Glasse. Zetidoline, a novel neuroleptic, activates nigral dopaminergic neurons in rats. Life sciences. vol 36. issue 5. 1985-03-18. PMID:2857469. |
zetidoline (zet), a rather selective dopamine (da) d2-receptor blocker, was found to be equipotent to haloperidol and over 300 times as potent as sulpiride in activating the firing rate of substantia nigra dopaminergic neurons (sn-da neurons) in unanesthetized rats. |
1985-03-18 |
2023-08-11 |
rat |
| J R Naranjo, J Del Ri. Locomotor activation induced in rodent by substance P and analogues. Blockade of the effect of substance P by met-enkephalin antiserum. Neuropharmacology. vol 23. issue 10. 1985-03-14. PMID:6084200. |
since the activating effect of substance p was also blocked by haloperidol, it is proposed that substance p produces behavioural excitation by activating dopaminergic systems, implicated in the control of locomotion, through interposed enkephalinergic neurones. |
1985-03-14 |
2023-08-12 |
mouse |
| G Pasinetti, S Govoni, F Battaini, P Locatelli, E Faccini, M Trabucch. Caerulein peripheral injection: a study on the correlation with dopaminergic metabolism. Pharmacological research communications. vol 16. issue 12. 1985-03-14. PMID:6522441. |
in addition, a very minute dose of haloperidol (25 /microgram/kg) potentiated the caerulein (0.25/microgram/kg) induced hypomotility, while the parameters of dopaminergic metabolism were unaffected. |
1985-03-14 |
2023-08-12 |
rat |
| M Sato, K Kashihara, T Harad. [Neuroleptic-induced dopaminergic supersensitivity following intermittent and continuous haloperidol administrations in rats]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. vol 86. issue 10. 1985-03-14. PMID:6522512. |
[neuroleptic-induced dopaminergic supersensitivity following intermittent and continuous haloperidol administrations in rats]. |
1985-03-14 |
2023-08-12 |
rat |
| K H Westermann, J Schmid. [Dopamine sensitivity of brain-induced behavior after repeated administration of dopamine agonists and antagonists]. Biomedica biochimica acta. vol 43. issue 7. 1985-02-05. PMID:6517885. |
comparative investigations were carried out on dopamine sensitivity, as judged by the rotational behavior of rats, of different nuclear areas of the central nervous system following repeated application of dopaminergic agonists, or the dopamine antagonist, haloperidol. |
1985-02-05 |
2023-08-12 |
rat |
| R L Wade, R M Quock, M H Malon. Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats. The Journal of pharmacy and pharmacology. vol 36. issue 10. 1985-01-10. PMID:6150084. |
these drug effects were sensitive to antagonism by haloperidol, a dopaminergic receptor blocker. |
1985-01-10 |
2023-08-12 |
rat |
| W F Gattaz, H Cramer, H Beckman. Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients. Biological psychiatry. vol 19. issue 8. 1985-01-04. PMID:6149769. |
this finding suggests that haloperidol and possibly other antipsychotic drugs might restore the cholinergic-dopaminergic balance in schizophrenia through central cholinergic stimulation in addition to the blockade of dopaminergic receptors. |
1985-01-04 |
2023-08-12 |
Not clear |
| M Ilhan, J P Long, J G Canno. Dopaminergic activity of a nonhydroxylated aminotetralin derivative (TL-68) on cat hearts. Archives internationales de pharmacodynamie et de therapie. vol 271. issue 2. 1984-12-28. PMID:6508433. |
these inhibitions were reversed by the dopaminergic antagonist haloperidol and not by the alpha2 adrenergic antagonist yohimbine. |
1984-12-28 |
2023-08-12 |
cat |
| H F Krous, A C Catron, J P Farbe. Norepinephrine-induced pulmonary petechiae in the rat: an experimental model with potential implications for sudden infant death syndrome. Pediatric pathology. vol 2. issue 1. 1984-12-28. PMID:6542210. |
the number of pulmonary petechiae was greatly reduced by alpha-adrenergic blockade (phentolamine) and dopaminergic blockade (haloperidol) but not by beta-adrenergic blockade (timolol). |
1984-12-28 |
2023-08-12 |
rat |
| A Kao, J M Kriett, H G Tobler, B L Detloff, M R Pritzker, D W Benson, D G Bendit. Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: studies in a canine model. Journal of the American College of Cardiology. vol 4. issue 6. 1984-12-27. PMID:6501720. |
in contrast, of five dogs pretreated with haloperidol, a central and peripheral dopaminergic receptor antagonist (group 4), bromocriptine, 50 micrograms/kg, failed to slow ventricular tachycardia in three, and two of the three developed ventricular fibrillation. |
1984-12-27 |
2023-08-12 |
Not clear |
| J A van der Heyde. Circling behaviour induced by electrical stimulation of the medial forebrain bundle, importance of stimulus parameters and dopaminergic processes. Pharmacology, biochemistry, and behavior. vol 21. issue 4. 1984-12-26. PMID:6334318. |
the contraversive circling behaviour was induced by activation of the ascending dopaminergic pathways as revealed by the close correlation between the site of stimulation and the localisation of this pathway, its antagonism by haloperidol and its abolishment by pretreatment with reserpine and alpha-methyl-p-tyrosine. |
1984-12-26 |
2023-08-12 |
Not clear |
| D Fage, B Guerin, C Feuerstein, P Demenge, B Scatto. Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat. Brain research. vol 310. issue 2. 1984-12-10. PMID:6488029. |
time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat. |
1984-12-10 |
2023-08-12 |
rat |
| M Ilhan, J P Long, R Bhatnagar, J Flynn, J G Cannon, T Le. TL-350, an ergoline derivative with dopamine receptor agonist properties. The Journal of pharmacology and experimental therapeutics. vol 231. issue 1. 1984-11-28. PMID:6548524. |
dopaminergic antagonists, haloperidol and sulpiride, antagonized the inhibitory effect of tl-350 in in vitro experiments. |
1984-11-28 |
2023-08-12 |
rat |
| T W McKeon, J F Lorden, G A Oltmans, M Beales, S U Walkle. Decreased catalepsy response to haloperidol in the genetically dystonic (dt) rat. Brain research. vol 308. issue 1. 1984-11-14. PMID:6541070. |
rats displaying clinical signs also show a decreased behavioral response to the dopaminergic blocker, haloperidol. |
1984-11-14 |
2023-08-12 |
rat |
| C J Billington, J E Morley, A S Levine, G C Gerritse. Feeding systems in Chinese hamsters. The American journal of physiology. vol 247. issue 3 Pt 2. 1984-10-24. PMID:6148021. |
dopaminergic blockade by haloperidol also limited feeding, and diabetic hamsters were more sensitive to this. |
1984-10-24 |
2023-08-12 |
rat |